Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use.

Mario Cottone; Tommaso Stefanelli; Manuela Marzo; Elisabetta Colombo; Michele Comberlato; Raffaella Pulitano; Maria Lia Scribano; Marcello Vangeli; Alberto Malesci; Alessandro Armuzzi; Silvio Danese; Cosimo Prantera; Luisa Guidi; Aldo Manca; Vito Annese

Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use.

Mario Cottone, Tommaso Stefanelli, Manuela Marzo, Elisabetta Colombo, Michele Comberlato, Raffaella Pulitano, Maria Lia Scribano, Marcello Vangeli, Alberto Malesci, Alessandro Armuzzi, Silvio Danese, Cosimo Prantera, Luisa Guidi, Aldo Manca, Vito Annese

Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”

Research output: Contribution to journal › Article › peer-review

21 Citations (Scopus)

Original language	English
Pages (from-to)	1168-1170
Number of pages	3
Journal	Inflammatory Bowel Diseases
Volume	14
Publication status	Published - 2008

All Science Journal Classification (ASJC) codes

Immunology and Allergy
Gastroenterology

Cite this

Cottone, M., Stefanelli, T., Marzo, M., Colombo, E., Comberlato, M., Pulitano, R., Scribano, M. L., Vangeli, M., Malesci, A., Armuzzi, A., Danese, S., Prantera, C., Guidi, L., Manca, A., & Annese, V. (2008). Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use. Inflammatory Bowel Diseases, 14, 1168-1170.

Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use. / Cottone, Mario; Stefanelli, Tommaso; Marzo, Manuela et al.

In: Inflammatory Bowel Diseases, Vol. 14, 2008, p. 1168-1170.

Research output: Contribution to journal › Article › peer-review

Cottone, M, Stefanelli, T, Marzo, M, Colombo, E, Comberlato, M, Pulitano, R, Scribano, ML, Vangeli, M, Malesci, A, Armuzzi, A, Danese, S, Prantera, C, Guidi, L, Manca, A & Annese, V 2008, 'Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use.', Inflammatory Bowel Diseases, vol. 14, pp. 1168-1170.

@article{fd0396af4f4f4919b661594f65344347,

title = "Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use.",

keywords = "Certolizumab, Crohn's disease, Refractory, Certolizumab, Crohn's disease, Refractory",

author = "Mario Cottone and Tommaso Stefanelli and Manuela Marzo and Elisabetta Colombo and Michele Comberlato and Raffaella Pulitano and Scribano, {Maria Lia} and Marcello Vangeli and Alberto Malesci and Alessandro Armuzzi and Silvio Danese and Cosimo Prantera and Luisa Guidi and Aldo Manca and Vito Annese",

year = "2008",

language = "English",

volume = "14",

pages = "1168--1170",

journal = "Inflammatory Bowel Diseases",

issn = "1078-0998",

publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use.

AU - Cottone, Mario

AU - Stefanelli, Tommaso

AU - Marzo, Manuela

AU - Colombo, Elisabetta

AU - Comberlato, Michele

AU - Pulitano, Raffaella

AU - Scribano, Maria Lia

AU - Vangeli, Marcello

AU - Malesci, Alberto

AU - Armuzzi, Alessandro

AU - Danese, Silvio

AU - Prantera, Cosimo

AU - Guidi, Luisa

AU - Manca, Aldo

AU - Annese, Vito

PY - 2008

Y1 - 2008

KW - Certolizumab

KW - Crohn's disease

KW - Refractory

KW - Certolizumab

KW - Crohn's disease

KW - Refractory

UR - http://hdl.handle.net/10447/45808

M3 - Article

SN - 1078-0998

VL - 14

SP - 1168

EP - 1170

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

ER -

Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use.

All Science Journal Classification (ASJC) codes

Other files and links

Cite this